NICOLE TUFFARELLI: Open Payments
NPI 1104988542 · GARDEN CITY, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,593 in 124 payments from 18 companies in 2025. Trend: 2023 $1,651 · 2024 $1,799 · 2025 $2,593
Food & beverage: $2,503Education: $90
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 20 | $385 |
| Janssen Biotech, Inc. | 18 | $332 |
| Lilly USA, LLC | 15 | $318 |
| GENZYME CORPORATION | 9 | $300 |
| Regeneron Healthcare Solutions, Inc. | 8 | $193 |
| Galderma Laboratories, L.P. | 4 | $182 |
| PFIZER INC. | 9 | $173 |
| E.R. Squibb & Sons, L.L.C. | 11 | $144 |
| UCB, Inc. | 9 | $138 |
| Incyte Corporation | 4 | $91 |
Products named: DUPIXENT, TREMFYA, RINVOQ, NEMLUVIO, CIBINQO, TALTZ, Sotyktu, Bimzelx.
Industry payments across NY — which companies pay providers there.
